YPSILANTI – Integrated Sensing Systems and the University of Michigan announced that they have received a $1.5 million National Institute of Health grant to develop a wireless, implantable pressure sensor for congenital heart disease.
?This pressure sensing implant has the potential to greatly improve the care we provide to our most complex patients and will provide us with unprecedented opportunities to learn more about their unique physiology,? said Dr. Martin Bocks, a pediatric cardiologist at the University of Michigan and the project?s medical principal investigator.
Dr. Nader Naiafi, ISSYS President and CEO, said this grant paves the way for the start of clinical studies in infants and children with complex congenital heart defects.
?The pediatric medical device field represents unique commercialization challenges due to its small size and stringent requirements,? he said. ?The University of Michigan is an ideal partner for us to develop this unique pediatric implant. The results of this effort will have important spillover effects for broader applications within the field of adult and pediatric cardiovascular medicine.?
ISSYS develops MEMS technologies for industrial, medical devices, microfluidic and scientific analytical sensing applications. Founded in 1995, ISSYS is one of the oldest independent MEMS companies in the US. ISSYS operates a full manufacturing under one roof, multi-million-dollar, state-of-the-art MEMS fabrication facility located near Ann Arbor, Michigan. An ISO 9001:2000 certified and ISO 13485:2003 (medical device manufacturing) qualified organization, ISSYS is a vertically integrated company dedicated to developing and manufacturing system-level products based on MEMS technology (MEMS Inside).
a>>
